AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2011
Jun 15, 2011
30826_dirs_2011-06-15_62503294-ff9c-4ff6-abb4-1325a2cf9859.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2011-06-14
Reporting Person: DAWES KAREN A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-14 | Common Stock | P | 3600 | $3.58 | Acquired | 5600 | Direct |
| 2011-06-14 | Common Stock | P | 200 | $3.53 | Acquired | 5800 | Direct |
| 2011-06-14 | Common Stock | P | 700 | $3.5572 | Acquired | 6500 | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23